Recurrent Shingles in a 64-Year-Old Woman: Causes and Evaluation
The most important cause to investigate in a 64-year-old woman with recurrent shingles is immunosuppression, particularly HIV infection, as HIV-infected adults have a >15-fold higher incidence of herpes zoster compared to age-matched controls, with 20-30% experiencing recurrent episodes 1.
Primary Causes to Investigate
Immunocompromised States (Most Critical)
- HIV infection: This is the single most important condition to rule out, as the incidence of herpes zoster is dramatically elevated in HIV-positive patients at any CD4+ count, though highest with CD4+ <200 cells/µL 1
- Malignancies: Particularly hematologic cancers and solid tumors
- Immunosuppressive medications: Corticosteroids, methotrexate, biologics, or other disease-modifying antirheumatic drugs 2
- Organ transplantation: Patients on chronic immunosuppression
Age-Related Immune Decline
At 64 years old, this patient falls into the high-risk age group where cellular immune response naturally declines, making VZV reactivation more likely 1, 3. However, truly recurrent episodes (multiple separate occurrences) should still prompt investigation for underlying immunosuppression.
Other Contributing Factors
- Chronic medical conditions: Cardiovascular disease increases recurrence risk (HR=1.20) 4
- Post-herpetic neuralgia from prior episode: Strongly associated with recurrence (HR=2.94) 4
- Female sex: Women have slightly higher recurrence rates (HR=1.08) 4
Clinical Context and Recurrence Patterns
The probability of herpes zoster recurrence within 1 year of the index episode is approximately 10% in HIV-infected patients 1. In the general population, recurrence rates are lower at 8.81 per 1000 person-years (3.6% overall) 4. The fact that this patient is experiencing continuous recurrences suggests either:
- Severe immunosuppression requiring immediate evaluation
- Misdiagnosis (could be recurrent herpes simplex rather than zoster)
- Chronic/persistent zoster (seen in severely immunocompromised hosts, particularly HIV) 5
Essential Diagnostic Workup
Immediate Laboratory Testing
- HIV testing: Mandatory first step
- Complete blood count with differential (evaluate for lymphopenia, cytopenias)
- Comprehensive metabolic panel
- Immunoglobulin levels
- Consider CD4+ count if HIV-positive
Additional Evaluation Based on History
- Screen for underlying malignancy if not recently evaluated
- Review all medications for immunosuppressive agents
- Assess for autoimmune conditions (rheumatoid arthritis, systemic lupus erythematosus have higher HZ rates) 6
Confirm Diagnosis
If presentation is atypical or "continuous," consider:
- Viral culture or PCR from active lesions to confirm VZV (not HSV)
- Distinguish true recurrent zoster from zoster sine herpete or chronic zoster 7
Critical Clinical Pitfalls
Do not assume recurrent shingles is simply "bad luck" in an older adult. While age >60 increases risk (HR=1.20) 4, truly recurrent episodes warrant investigation. The guideline evidence emphasizes that recurrence of herpes zoster is unusual in immunocompetent persons 8, and approximately 20-30% of HIV-infected patients experience one or more subsequent episodes 1.
Avoid delaying HIV testing due to patient demographics or perceived risk factors—this is the most treatable cause of recurrent zoster and has the highest relative risk increase.
Management Implications
Once immunosuppression is identified or ruled out:
- If HIV-positive: Initiate antiretroviral therapy (ART), though ART does not reduce zoster frequency, it improves overall immune function 1
- If on immunosuppressive medications: Discuss risk-benefit with prescribing specialist
- No drug has been proven to prevent recurrence of shingles in HIV-infected persons 9, though some experts consider suppressive antiviral therapy in severe cases
- Consider recombinant zoster vaccine (RZV) if immunocompetent or mildly immunosuppressed 3
The key is identifying the underlying cause rather than simply treating each episode as it occurs.